You are here: Industry Insights > Microbiome

News List

Microbiome biotherapeutic shows promise in acute graft-versus-host disease europeanpharmaceuticalreview
March 22, 2021
MaaT013 was safe and generated complete or very good partial responses in a third of patients with steroid-refractory, gastrointestinal-predominant acute graft-versus-host disease.
Assembly Biosciences to Wind-Down Microbiome Program americanpharmaceuticalreview
December 30, 2020
Assembly Biosciences will wind-down its microbiome program, enabling the company to prioritize resources and focus on the advancement of its pipeline of novel core inhibitors for chronic hepatitis B virus (HBV).
BiomX collaborates with Boehringer Ingelheim for microbiome-based biomarkers for IBD expresspharma
September 03, 2020
The terms of the collaboration also include an option for Boehringer Ingelheim to negotiate an exclusive right to biomarkers discovered utilising the XMarker platform.
Kids' 'Microbiome' May Play Key Role in Asthma drugs
December 25, 2019
Microbes that live in a child's upper airway could be linked to severe asthma attacks, new research suggests.For parents, it's an all-too familiar scene: A child's seemingly harmless cough quickly escalates to wheezing, gasping and an urgent need for emer
Could Red Wine Boost Your 'Microbiome'? drugs
August 29, 2019
A little pinot noir now and then might help keep the bacteria in your tummy healthy and happy, a new study suggests.
Scientists Creating Gene Map of Human 'Microbiome' drugs
August 15, 2019
The number of genes in bacteria that live in and on people could top 1 billion trillion -- and at least half appear to be unique to their host.
Ex-GSK immunology chief to lead Flagship startup Kintai Therapeutics fiercebiotech
April 17, 2019
Flagship Pioneering is launching Kintai Therapeutics with Dr. Paul-Peter Tak, a former GlaxoSmithKline executive, at the helm. Tak signs on ...
Newly discovered link between the appendix and Parkinson’s disease could point to the way to treatments fiercebiotech
November 02, 2018
Scientists led by the Van Andel Research Institute in Michigan scoured two large patient registries, encompassing data from 1.7 million people, and made an astounding ...
Microbiome startup Nextbiotix raises €7M to tackle inflammatory bowel diseases fiercebiotech
July 09, 2018
Nextbiotix has raised €7 million ($8 million) to develop a bacterial treatment for inflammatory bowel diseases. The series A round will support work to rebalance the gut microbiome through the delivery of Faecalibacterium prausnitzii, one of the most abun
Bloom bags cash, UCLA tech to treat epilepsy via the microbiome fiercebiotech
May 29, 2018
Bloom Science has raised seed money and licensed technology to treat CNS diseases via the gut-brain axis. Building on research into the ketogenic diet, Bloom is initially focusing on developing bacterial treatments for epilepsy.

Previous page 1 2 3 Next page